Immunic Inc.

NASDAQ: IMUX · Real-Time Price · USD
0.90
-0.02 (-1.80%)
At close: Aug 15, 2025, 3:59 PM
0.91
1.27%
After-hours: Aug 15, 2025, 07:58 PM EDT

Immunic Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
35.67M 46.67M 106.75M 86.86M
Short-Term Investments
n/a n/a 9.63M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a 43K 42K
Receivables
684K 703K 296K 279K
Inventory
n/a n/a 5.61M -2.15M
Other Current Assets
1.11M 2.84M -2.02M 5.14M
Total Current Assets
39.33M 52.53M 125.86M 104.99M
Property-Plant & Equipment
1.54M 1.76M 1.85M 1.1M
Goodwill & Intangibles
n/a n/a n/a 32.97M
Total Long-Term Assets
1.54M 1.76M 1.89M 34.11M
Total Assets
40.87M 54.3M 127.75M 139.1M
Account Payables
7.85M 5.1M 4.28M 3.75M
Deferred Revenue
n/a n/a n/a 6.66M
Short-Term Debt
n/a n/a 571K 408K
Other Current Liabilities
676K 17.48M 6.76M -497K
Total Current Liabilities
22.18M 24.73M 13.08M 11.4M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
264K 639K 992K 584K
Total Liabilities
22.44M 25.37M 14.07M 11.98M
Total Debt
1M 1.33M 1.56M 992K
Common Stock
8K 4K 4K 3K
Retained Earnings
-511.4M -410.89M -317.28M -196.87M
Comprehensive Income
4.21M 3.76M 3.04M -252K
Shareholders Equity
18.43M 28.93M 113.68M 127.11M
Total Investments
n/a n/a 9.63M n/a